SUBSCRIBE
SUBSCRIBE
News   Business

Celgene Reports Record Second Quarter 2011 Operating and Financial Results

July 28, 2011 | 
1 min read
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG): 2011 Second Quarter Financial Results Year-Over-Year. Non-GAAP Total Revenue Increased 38 Percent to $1.18 Billion; GAAP Total Revenue $1.18 Billion
Earnings
MORE ON THIS TOPIC
Balance vaccination and anti-vaccination. Vaccination or Anti-vaccination concept, vector illustration
Earnings
GSK vaccine sales miss expectations amid falling demand from adults
October 28, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Hand shake icon on wooden cube block which connection with human icon for business deal and agreement concept.
Immuno-oncology
Astellas bets up to $1.34B for option to advance Audax immuno-oncology asset
October 28, 2026
 · 
2 min read
 · 
Tristan Manalac
Business growth or increase in professional income, business operations, investment profits or interest on savings, increase in interest rates, businessman holding gold coins forming a growing arrow symbol.
Earnings
Biogen notches 3rd straight quarter of growth thanks to newer products, Apellis
October 28, 2026
 · 
1 min read
 · 
Annalee Armstrong
Podcast
Data leak kickstarts ESMO, BMS reports autoimmune CAR T death, pharma M&A outpaces 2025
October 28, 2026
 · 
1 min read
 · 
Jef Akst